American International Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,480
| Closed | -$34.2K | – | 2993 |
|
|
2024
Q1 | $34.2K | Sell |
21,480
-184
| -0.8% | -$293 | ﹤0.01% | 2859 |
|
|
2023
Q4 | $18.6K | Sell |
21,664
-87
| -0.4% | -$75 | ﹤0.01% | 2972 |
|
|
2023
Q3 | $23.3K | Buy |
21,751
+773
| +4% | +$827 | ﹤0.01% | 2969 |
|
|
2023
Q2 | $54.3K | Buy |
20,978
+1,466
| +8% | +$3.8K | ﹤0.01% | 2860 |
|
|
2023
Q1 | $79.6K | Buy |
19,512
+388
| +2% | +$1.58K | ﹤0.01% | 2553 |
|
|
2022
Q4 | $96K | Buy |
19,124
+250
| +1% | +$1.26K | ﹤0.01% | 2539 |
|
|
2022
Q3 | $247K | Buy |
18,874
+523
| +3% | +$6.84K | ﹤0.01% | 2041 |
|
|
2022
Q2 | $235K | Buy |
18,351
+2,708
| +17% | +$34.7K | ﹤0.01% | 2086 |
|
|
2022
Q1 | $239K | Sell |
15,643
-1,101
| -7% | -$16.8K | ﹤0.01% | 2133 |
|
|
2021
Q4 | $297K | Sell |
16,744
-501
| -3% | -$8.89K | ﹤0.01% | 2126 |
|
|
2021
Q3 | $362K | Sell |
17,245
-410
| -2% | -$8.61K | ﹤0.01% | 2062 |
|
|
2021
Q2 | $348 | Buy |
17,655
+2,660
| +18% | +$52 | ﹤0.01% | 2160 |
|
|
2021
Q1 | $436 | Buy |
14,995
+1,134
| +8% | +$33 | ﹤0.01% | 1909 |
|
|
2020
Q4 | $420 | Sell |
13,861
-398
| -3% | -$12 | ﹤0.01% | 1854 |
|
|
2020
Q3 | $227K | Sell |
14,259
-98
| -0.7% | -$1.56K | ﹤0.01% | 2070 |
|
|
2020
Q2 | $283K | Sell |
14,357
-98
| -0.7% | -$1.93K | ﹤0.01% | 1924 |
|
|
2020
Q1 | $178K | Sell |
14,455
-834
| -5% | -$10.3K | ﹤0.01% | 1967 |
|
|
2019
Q4 | $283K | Buy |
15,289
+10,974
| +254% | +$203K | ﹤0.01% | 2006 |
|
|
2019
Q3 | $60K | Buy |
4,315
+38
| +0.9% | +$528 | ﹤0.01% | 2840 |
|
|
2019
Q2 | $63K | Buy |
+4,277
| New | +$63K | ﹤0.01% | 2887 |
|